DHA/EPA (Omega-3) and LA/GLA (Omega-6) as Bioactive Molecules in Neurodegenerative Diseases
International Journal of Molecular Sciences · 27.06.2023 · 24 (13) · 10717
DOI: 10.3390/ijms241310717 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.06.2023. Verfasst von Christina Kousparou und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, European University Cyprus, 6 Diogenous Str., 2404 Nicosia, Cyprus. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Fatty Acids, Omega-3. Die Arbeit wurde bisher 127-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Neurodegenerative diseases are characterized by neuroinflammation, neuronal depletion and oxidative stress. They coincide with subtle chronic or flaring inflammation, sometimes escalating with infiltrations of the immune system cells in the inflamed parts causing mild to severe or even lethal damage. Thus, neurodegenerative diseases show all features of autoimmune diseases. Prevalence of neurodegenerative diseases has dramatically increased in recent decades and unfortunately, the therapeutic efficacy and safety profile of available drugs is moderate. The beneficial effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) polyunsaturated fatty acids (omega-3 PUFAs) are nowadays highlighted by a plethora of studies. They play a role in suppression of inflammation, gene expression, cellular membrane fluidity/permeability, immune functionality and intracellular/exocellular signaling. The role of omega-6 polyunsaturated fatty acids, such as linoleic acid (LA), gamma linolenic acid (GLA), and arachidonic acid (AA), on neuroprotection is controversial, as some of these agents, specifically AA, are proinflammatory, whilst current data suggest that they may have neuroprotective properties as well. This review provides an overview of the existing recent clinical studies with respect to the role of omega-3 and omega-6 PUFAs as therapeutic agents in chronic, inflammatory, autoimmune neurodegenerative diseases as well as the dosages and the period used for testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, European University Cyprus, 6 Diogenous Str., 2404 Nicosia, Cyprus.
Zitieren
APA
Kousparou, C., Fyrilla, M., Stephanou, A., & Patrikios, I. (2023). DHA/EPA (Omega-3) and LA/GLA (Omega-6) as Bioactive Molecules in Neurodegenerative Diseases. International Journal of Molecular Sciences, 24(13), 10717. https://doi.org/10.3390/ijms241310717
Vancouver
Kousparou C, Fyrilla M, Stephanou A, Patrikios I. DHA/EPA (Omega-3) and LA/GLA (Omega-6) as Bioactive Molecules in Neurodegenerative Diseases. International Journal of Molecular Sciences. 2023;24(13):10717. doi:10.3390/ijms241310717
BibTeX
@article{Kousparou2023,
author = {Kousparou, Christina and Fyrilla, Maria and Stephanou, Anastasis and Patrikios, Ioannis},
title = {DHA/EPA (Omega-3) and LA/GLA (Omega-6) as Bioactive Molecules in Neurodegenerative Diseases},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {13},
pages = {10717},
doi = {10.3390/ijms241310717}
}
EUVIMED